• Evaluating Chloroquine’s Antiviral Evidence in COVID-19 Cont

  2026-07-07

  Touret and de Lamballerie’s commentary critically reviews the historical and emerging data on chloroquine as an antiviral agent, with a particular focus on its relevance to SARS-CoV-2. Their analysis underscores the disconnect between robust in vitro efficacy and limited or absent clinical benefit in acute viral infections, informing future translational research directions.

• Quizartinib (AC220): Mechanisms and Strategies for Translati

  2026-07-07

  This article delivers a strategic, mechanistic perspective on Quizartinib (AC220), focusing on its role as a selective FLT3 inhibitor in acute myeloid leukemia (AML) research. We synthesize recent advances in FLT3 signaling, experimental validation, and emerging resistance challenges—offering translational researchers actionable guidance, protocol recommendations, and a vision for future AML model optimization. The discussion integrates insights from foundational literature and recent virology findings to contextualize cell death regulation in hematologic malignancies.

• Pregnenolone Carbonitrile: Advanced Workflows in Hepatic Res

  2026-07-06

  Pregnenolone Carbonitrile from APExBIO empowers precise modeling of hepatic detoxification and fibrosis in rodent systems, enabling robust cytochrome P450 CYP3A induction and antifibrotic studies. This guide translates the latest protocol advances and troubleshooting strategies for reproducible, high-impact results.

• Dasatinib Monohydrate in CML Research: Protocols & Innovatio

  2026-07-06

  Dasatinib Monohydrate (BMS-354825) enables robust modeling of imatinib-resistant BCR-ABL signaling, neutrophil extracellular trap (NET) dynamics, and kinase-driven tumor biology in CML and Ph+ ALL. This guide delivers actionable workflow enhancements, troubleshooting strategies, and practical insights from recent mechanistic breakthroughs.

• Redefining mRNA Translation: Strategic Leverage of N1-Methyl

  2026-07-05

  This thought-leadership article offers translational researchers a mechanistic and strategic deep dive into the use of N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) for advanced RNA engineering, emphasizing its role in mRNA vaccine innovation, immune evasion, and translational efficiency. By synthesizing recent literature, experimental evidence, and workflow guidance, it provides a roadmap for maximizing the impact of modified nucleotides in next-generation mRNA therapeutics.

• Bleomycin Sulfate for Pulmonary Fibrosis & Oncology Models

  2026-07-04

  Bleomycin Sulfate (Blenoxane) is the gold standard for modeling DNA strand breaks in both cancer and fibrosis research, with precise control over dose-response and pathway activation. This article details advanced experimental workflows, troubleshooting strategies, and the latest innovations, enabling researchers to unlock the full potential of this versatile reagent.

• Olive Biophenols Attenuate Amyloid Pathology in AD Models

  2026-07-03

  This study demonstrates that olive-derived biophenols, especially oleuropein, verbascoside, and rutin, reduce amyloid beta toxicity and plaque burden in cellular and transgenic mouse models of Alzheimer's disease. The findings highlight a natural, multi-targeted approach to modulating amyloid aggregation and oxidative stress, offering new directions for AD research and therapeutic development.

• Catalpol Applications: Protocol Enhancements in Disease Mode

  2026-07-03

  Catalpol delivers robust, multi-pathway modulation for neuroprotection, osteoporosis, and liver fibrosis research. This guide translates the latest evidence and workflow innovations into practical, reproducible steps for maximizing Catalpol’s impact in complex disease models.

• Anlotinib Hydrochloride: Advanced Mechanisms and Translation

  2026-07-02

  Explore the advanced anti-angiogenic mechanisms of Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor. This article provides a deeply analytical perspective on its unique molecular action, pharmacokinetics, and translational utility in cancer research—delivering insight beyond standard product summaries.

• FDA-Approved Drug Repurposing Identifies Lopinavir as a MERS

  2026-07-02

  The study by de Wilde et al. systematically screened FDA-approved compounds for activity against MERS-CoV, revealing four small molecules—including Lopinavir (ABT-378)—with low-micromolar inhibitory activity in cell culture. These findings highlight the potential for rapid repurposing of established antivirals in emerging coronavirus outbreaks and establish a foundation for further translational research.

• Dasatinib (BMS-354825): Precision Kinase Inhibition in Tumor

  2026-07-01

  Explore how Dasatinib (BMS-354825) enables advanced research into tumor microenvironment signaling, with new insights on kinase inhibition in EMT and cancer stemness. This article uniquely bridges molecular mechanisms with practical assay design.

• Safe DNA Gel Stain: Elevating DNA and RNA Gel Stain Workflow

  2026-07-01

  Safe DNA Gel Stain from APExBIO redefines nucleic acid visualization by combining high sensitivity with a dramatically improved safety profile. Its blue-light excitation capabilities not only minimize DNA damage but also streamline workflows for cloning and molecular diagnostics, setting a new benchmark for DNA and RNA gel stain applications.

• Super-Enhancer Regulation of Disulfidptosis in Prostate Canc

  2026-06-30

  This study identifies a super-enhancer–FOXA1–SLC7A11 regulatory axis as a driver of disulfidptosis in prostate cancer, revealing how super-enhancers promote SLC7A11 expression and cytoskeletal collapse under glucose starvation. The findings suggest that targeting this pathway could provide new therapeutic strategies for advanced prostate cancer, especially in metabolically stressed tumor microenvironments.

• Anlotinib in Desmoplastic Small Round Cell Tumor: Case Evide

  2026-06-30

  This article reviews a unique clinical case and literature analysis demonstrating the efficacy of anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, in treating intra-abdominal desmoplastic small round cell tumor (IADSRCT). The findings highlight the therapeutic potential of multi-kinase inhibition for rare, aggressive sarcomas with limited treatment options.

• EGTA in Calcium Signaling: Workflows, Innovations & Troubles

  2026-06-29

  EGTA (egtzic acid) offers unparalleled precision in modulating calcium-dependent processes, enabling researchers to dissect mechanisms in neuroprotection, apoptosis, and vascular inflammation. This article provides actionable protocols, highlights innovations from recent endothelial research, and delivers troubleshooting insights to maximize experimental reliability using APExBIO’s EGTA.

14899 records 1/994 page Next 12345 下5页 Last page